EUVIMEDEUVIMED entdecken
Fallbericht

Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary

Arantzazu Barquín García, Sara Palacios-Zambrano, Felipe Lozano Alarcón, Beatriz Paumard-Hernández, Miguel Quiralte Pulido, Paloma Navarro, Laura Rodríguez, Isabel Salas Villar, Jesús García-Donas

Journal of the National Comprehensive Cancer Network · 2024

DOI: 10.6004/jnccn.2023.7079 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024. Verfasst von Arantzazu Barquín García und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gynecological, Genitourinary, and Skin Cancer Unit, HM CIOCC Madrid (Centro Integral Oncológico Clara Campal), Hospital Universitario HM Sanchinarro,…. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Papillomavirus Infections, Carcinoma, Uterine Cervical Neoplasms. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report presents the case of a 62-year-old woman who was diagnosed in 1999 with stage I cervical carcinoma treated by surgical resection. In 2021, she presented to the emergency department with a complaint of predominantly right-sided lower back pain. A CT scan of the lumbosacral region revealed a bone lesion in the L5 vertebra and retroperitoneal lymphadenopathies suggestive of malignancy. Histology of the L5 vertebra biopsy showed a poorly differentiated carcinoma with an inconclusive immunophenotypic profile. Treatment for carcinoma of unknown primary was started with a combination of carboplatin and paclitaxel every 21 days. A genomic study of the biopsy specimen performed on the FoundationOne CDx platform identified a nonhuman genetic signature compatible with HPV. The presence of HPV 18 DNA in the specimen was confirmed by PCR-reverse dot blot, and the immunophenotypic profile was expanded, revealing strong and diffuse p16 expression, thus corroborating the molecular findings. In view of these findings, the case was reclassified as a recurrence of the cervical adenocarcinoma that had been diagnosed and treated 23 years earlier. Based on the new results, and according to first-line cervical carcinoma protocols, bevacizumab at 15 mg/kg every 21 days was added to her chemotherapy regimen. The identification of HPV DNA sequences by next-generation sequencing facilitated the correct diagnosis and led to a modification of the first-line therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Unknown PrimaryPapillomavirus InfectionsCarcinomaUterine Cervical NeoplasmsHumansFemaleMiddle AgedBevacizumabPaclitaxel

Stichwörter der Autor:innen

HPValgorithmcarnomanext generation sequencingunkown origin

Substanzen

BevacizumabPaclitaxel

Autor:innen und Institutionen

  • Gynecological, Genitourinary, and Skin Cancer Unit, HM CIOCC Madrid (Centro Integral Oncológico Clara Campal), Hospital Universitario HM Sanchinarro, HM Hospitales, Madrid, Spain.
  • Institute of Applied Molecular Medicine (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo CEU, CEU Universities, Urbanización Montepríncipe, Madrid, Spain.
  • Department of Pathology-Therapeutic Target Laboratory, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Laboratorio de Genética Molecular AbaCid, Hospital Universitario HM Sanchinarro, Madrid, Spain.

Zitieren

APA

Barquín García, A., Palacios-Zambrano, S., Lozano Alarcón, F., Paumard-Hernández, B., Quiralte Pulido, M., Navarro, P., Rodríguez, L., Salas Villar, I., & García-Donas, J. (2024). Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2023.7079

Vancouver

Barquín García A, Palacios-Zambrano S, Lozano Alarcón F, Paumard-Hernández B, Quiralte Pulido M, Navarro P, et al. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary. Journal of the National Comprehensive Cancer Network. 2024. doi:10.6004/jnccn.2023.7079

BibTeX
@article{BarqunGarca2024,
  author = {Barquín García, Arantzazu and Palacios-Zambrano, Sara and Lozano Alarcón, Felipe and Paumard-Hernández, Beatriz and Quiralte Pulido, Miguel and Navarro, Paloma and Rodríguez, Laura and Salas Villar, Isabel and García-Donas, Jesús},
  title = {Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  doi = {10.6004/jnccn.2023.7079}
}
Kostenlos starten →